Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 419

1.

Asthma and chronic obstructive pulmonary disease inhalers: Techniques for proper use.

Pepper AN, Cooke A, Livingston L, Lockey RF.

Allergy Asthma Proc. 2016 Jul;37(4):279-90. doi: 10.2500/aap.2016.37.3954.

PMID:
27401315
2.

Chronic Rhinosinusitis Phenotypes: An Approach to Better Medical Care for Chronic Rhinosinusitis.

Cho SH, Bachert C, Lockey RF.

J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):639-42. doi: 10.1016/j.jaip.2016.05.007. No abstract available.

PMID:
27393778
3.

Aspirin or Nonsteroidal Anti-inflammatory Drug-Exacerbated Chronic Rhinosinusitis.

Ledford DK, Lockey RF.

J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):590-8. doi: 10.1016/j.jaip.2016.04.011.

PMID:
27393773
4.

4-hydroxy-2-nonenal: a critical target in oxidative stress?

Breitzig M, Bhimineni C, Lockey R, Kolliputi N.

Am J Physiol Cell Physiol. 2016 Jul 6:ajpcell.00101.2016. doi: 10.1152/ajpcell.00101.2016. [Epub ahead of print]

PMID:
27385721
5.

Pediatric Sleep Apnea Syndrome: An Update.

Li Z, Celestin J, Lockey RF.

J Allergy Clin Immunol Pract. 2016 Jun 30. pii: S2213-2198(16)30105-2. doi: 10.1016/j.jaip.2016.02.022. [Epub ahead of print] Review.

PMID:
27372597
6.

Coseasonal Initiation of Allergen Immunotherapy: A Systematic Review.

Creticos PS, Bernstein DI, Casale TB, Lockey RF, Maloney J, Nolte H.

J Allergy Clin Immunol Pract. 2016 Jun 24. pii: S2213-2198(16)30153-2. doi: 10.1016/j.jaip.2016.05.014. [Epub ahead of print]

PMID:
27349175
7.

Subcutaneous versus sublingual immunotherapy.

Lin CH, Alandijani S, Lockey RF.

Expert Rev Clin Immunol. 2016 Aug;12(8):801-3. doi: 10.1080/1744666X.2016.1196137. Epub 2016 Jun 16. No abstract available.

PMID:
27253418
8.

TEMPORARY REMOVAL: The importance of knowing how allergen extracts are manufactured.

Lockey RF.

Ann Allergy Asthma Immunol. 2016 Apr 19. pii: S1081-1206(16)30093-X. doi: 10.1016/j.anai.2016.03.032. [Epub ahead of print] No abstract available.

PMID:
27102342
9.

SOCS-1 rescues IL-1β-mediated suppression of epithelial sodium channel in mouse lung epithelial cells via ASK-1.

Galam L, Soundararajan R, Breitzig M, Rajan A, Yeruva RR, Czachor A, Harris F, Lockey RF, Kolliputi N.

Oncotarget. 2016 Apr 1. doi: 10.18632/oncotarget.8543. [Epub ahead of print]

10.

Case study: Idiopathic hemothorax in a patient with status asthmaticus.

Ricketti PA, Unkle DW, Lockey R, Cleri DJ, Ricketti AJ.

J Asthma. 2016 Sep;53(7):770-3. doi: 10.3109/02770903.2016.1155216. Epub 2016 Apr 6.

PMID:
27042969
11.

TEMPORARY REMOVAL: Pollen used to produce allergen extracts.

Codina R, Lockey RF.

Ann Allergy Asthma Immunol. 2016 Mar 16. pii: S1081-1206(16)00092-2. doi: 10.1016/j.anai.2016.02.005. [Epub ahead of print] No abstract available.

PMID:
26993170
12.

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.

Stempel DA, Raphiou IH, Kral KM, Yeakey AM, Emmett AH, Prazma CM, Buaron KS, Pascoe SJ; AUSTRI Investigators.

N Engl J Med. 2016 May 12;374(19):1822-30. doi: 10.1056/NEJMoa1511049. Epub 2016 Mar 6.

13.

Pivotal role of AKAP121 in mitochondrial physiology.

Czachor A, Failla A, Lockey R, Kolliputi N.

Am J Physiol Cell Physiol. 2016 Apr 15;310(8):C625-8. doi: 10.1152/ajpcell.00292.2015. Epub 2016 Jan 28.

PMID:
26825124
14.

Deletion of ASK1 Protects against Hyperoxia-Induced Acute Lung Injury.

Fukumoto J, Cox R Jr, Fukumoto I, Cho Y, Parthasarathy PT, Galam L, Lockey RF, Kolliputi N.

PLoS One. 2016 Jan 25;11(1):e0147652. doi: 10.1371/journal.pone.0147652. eCollection 2016.

15.

Deletion of P2X7 attenuates hyperoxia-induced acute lung injury via inflammasome suppression.

Galam L, Rajan A, Failla A, Soundararajan R, Lockey RF, Kolliputi N.

Am J Physiol Lung Cell Mol Physiol. 2016 Mar 15;310(6):L572-81. doi: 10.1152/ajplung.00417.2015. Epub 2016 Jan 8.

PMID:
26747786
16.

[WAO Guideline for the Management of Hereditary Angioedema].

Craig T, Pürsün EA, Bork K, Bowen T, Boysen H, Farkas H, Grumach A, Katelaris CH, Lockey R, Longhurst H, Lumry W, Magerl M, Martinez-Saguer I, Ritchie B, Nast A, Pawankar R, Zuraw B, Maurer M.

Arerugi. 2015 Sep;64(9):1215-41. doi: 10.15036/arerugi.64.1215. Japanese. No abstract available.

PMID:
26657910
17.

Solving the Problem of Nonadherence to Immunotherapy.

Bender BG, Lockey RF.

Immunol Allergy Clin North Am. 2016 Feb;36(1):205-13. doi: 10.1016/j.iac.2015.08.014. Review.

PMID:
26617236
18.

Commentary: The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension.

Bhavanam NP, Failla A, Cho Y, Lockey RF, Kolliputi N.

Front Pharmacol. 2015 Oct 19;6:229. doi: 10.3389/fphar.2015.00229. eCollection 2015. No abstract available.

19.

2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines.

Simons FE, Ebisawa M, Sanchez-Borges M, Thong BY, Worm M, Tanno LK, Lockey RF, El-Gamal YM, Brown SG, Park HS, Sheikh A.

World Allergy Organ J. 2015 Oct 28;8(1):32. doi: 10.1186/s40413-015-0080-1. eCollection 2015.

20.

Administration and Burden of Subcutaneous Immunotherapy for Allergic Rhinitis in U.S. and Canadian Clinical Practice.

Blume SW, Yeomans K, Allen-Ramey F, Smith N, Kim H, Lockey RF, Nichol MB.

J Manag Care Spec Pharm. 2015 Nov;21(11):982-90.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk